Limin：5,000 tons of Glufosinate ammonium and new green biological products manufacturing projects have reached production

An investor asked on the investor interactive platform: Did the three projects of your company reach production last year? How is the production and sales of Mancozeb in the first half of the year? What are the changes in upstream raw material prices and costs and gross margins?

Limin Shares said on the investor interactive platform on September 26 that the company's 12,000 tons of Fosetyl-aluminum, 5,000 tons of Glufosinate ammonium and new green biological products manufacturing projects have reached production, which not only expanded the capacity scale and laid a good foundation for the increase of new business, but also achieved the progress of equipment, process technology and safety and environmental protection level. The application of advanced equipment such as countercurrent extraction, membrane filtration and concentration, and the application of new technologies such as gas phase continuous method and micro-channel continuous reaction, not only reduces the unit reaction time from hours to seconds, but also improves the product yield and quality, the product cost reaches the lowest level in the industry, builds the core competitiveness, and accumulates the kinetic energy of high-quality development.

Limin shares expressed that in the first half of the year, the group's production and operation were generally stable and orderly, and the production and sales volume of Mancozeb increased by more than 30% compared with the same period last year. The company strives to overcome the adverse impact of lower prices by exploiting potential efficiencies and reducing costs, and the upstream raw material prices continue to decrease, and the gross profit margin of Mancozeb has been improved.